Update on tuberculosis and other opportunistic infections associated with drugs blocking tumour necrosis factor α

Por Winthrop, K
Publicado em 2005

Serious infections with antirheumatic therapy: are biologicals worse?

Por Winthrop, K L
Publicado em 2006

Herpes Zoster and the Risk for Stroke in Patients with Autoimmune Diseases

Por Calabrese, LH, Xie, F, Yun, H, Winthrop, K, Baddley, JW, Calabrese, C, Curtis, JR
Publicado no Arthritis Rheumatol (2017)

Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials

Por Bykerk, V P, Cush, J, Winthrop, K, Calabrese, L, Lortholary, O, de Longueville, M, van Vollenhoven, R, Mariette, X
Publicado no Ann Rheum Dis (2015)

Incidence and Risk Factors for Progressive Multifocal Leukoencephalopathy among Patients with Selected Rheumatic Diseases

Por Bharat, A, Xie, F, Baddley, JW, Beukelman, T, Chen, L, Calabrese, L, Delzell, E, Grijalva, CG, Patkar, N, Saag, K, Winthrop, K, Curtis, JR
Publicado em 2012

Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis

Por Winthrop, K L, Park, S-H, Gul, A, Cardiel, M H, Gomez-Reino, J J, Tanaka, Y, Kwok, K, Lukic, T, Mortensen, E, Ponce de Leon, D, Riese, R, Valdez, H
Publicado no Ann Rheum Dis (2016)